Tagged: gilly regev

February 9, 2022 @ 7:08 pm By JD Alois  |  

SaNOtize, an OurCrowd portfolio company, has shown to be 99% effective against COVID-19 in a phase three trial, according to a note distributed by OurCrowd. Simultaneously, the treatment has received regulatory approval in India. OurCrowd has participated in the funding of the firm providing access… Read More

March 22, 2021 @ 7:03 am By JD Alois  |  

OurCrowd portfolio company SaNOtize Research & Development Corp. has received interim approval to sell its COVID-19 treatment Nitric Oxide Nasal Spray (NONS). The spray is said to protect users from viruses that enter the body through the upper nasal pathways. The spray will be sold… Read More